...
首页> 外文期刊>Journal of Heterocyclic Chemistry: The International Journal of Heterocyclic Chemistry >Synthesis of Novel Tricyclic 1,5-Benzothiazepine Derivatives Bearing Quinoline Moiety via [2 + 2] Cycloaddition Reaction
【24h】

Synthesis of Novel Tricyclic 1,5-Benzothiazepine Derivatives Bearing Quinoline Moiety via [2 + 2] Cycloaddition Reaction

机译:通过[2 + 2]环加成反应合成具有喹啉部分的新型三环1,5-苯并噻庚因衍生物

获取原文
获取原文并翻译 | 示例

摘要

1,5-Benzothiazepine is an important seven-membered heterocyclic ring system. It has attracted considerable attention to synthetic and medicinal chemists because of their broad spectrum of biological activities. It has been used as a calcium antagonist [1], antibacterial [2], anticancer drug[3,4], anticonvulsant, tranquilizer [5], and antidepressant[6]. For example, the drug diltiazem, intensively used in clinical practice, contains this system. It is well documented that pharmaceutical properties of such compounds are magnified when an additional heterocyclic is bound to the heptatomic nucleus [7-9]. To search for new potential useful 1,5-benzothiazepine derivatives, a great deal of work has been carried out on the synthesis of tricyclic 1,5-benzothiazepine derivatives in recent years [10].
机译:1,5-苯并噻氮平是重要的七元杂环系统。由于其广泛的生物活性,它已经引起了合成化学和药物化学家的极大关注。它已被用作钙拮抗剂[1],抗菌剂[2],抗癌药[3,4],抗惊厥药,镇定剂[5]和抗抑郁药[6]。例如,在临床实践中大量使用的地尔硫卓药物含有该系统。有充分的文献记载,当另外的杂环键合到七原子核上时,此类化合物的药理特性会放大[7-9]。为寻找新的潜在有用的有用的1,5-苯并噻氮平衍生物,近年来在合成三环1,5-苯并噻氮平衍生物方面进行了大量工作[10]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号